7. SHAREHOLDERS' EQUITY

3 Months Ended

Nov. 30, 2019

Equity [Abstract]

SHAREHOLDERS' EQUITY

NOTE 7: SHAREHOLDERS’ EQUITY

Dividend

The Company’s Board of Directors declared cash dividends during fiscal years 2020 and 2019. The details of the dividends paid are in the following tables:

FY2020
Record Date	Distribution Date	Number of Shares Outstanding on Record Date		Dividend per Share		Total Amount
10/25/2019	11/01/2019		17,606,314	$	0.06	$	1,056,379
Total						$	1,056,379

FY2019
Record Date	Distribution Date	Number of Shares Outstanding on Record Date		Dividend per Share		Total Amount
11/01/2018	11/08/2018		17,417,875	$	0.06	$	1,045,073
1/25/2019	2/1/2019		17,481,450		0.06		1,048,887
4/24/2019	5/1/2019		17,515,228		0.06		1,050,914
7/25/2019	8/1/2019		17,536,454	$	0.06		1,052,181
Total						$	4,197,055

Stock Option Plan

On February 23, 2007, the Board of Directors adopted and the shareholders approved the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had been reserved for issuance. On February 25, 2014 the shareholders approved an additional 1,000,000 shares increasing the total number of shares that may be granted under the Option Plan to 2,000,000. This plan terminated in February 2017 by its term.

On December 23, 2016 the Board of Directors adopted, and on February 23, 2017 the shareholders approved, the 2017 Equity Incentive Plan under which a total of 1,000,000 shares of common stock has been reserved for issuance. This plan will terminate in December 2026.

As of November 30, 2019, employees and directors hold Qualified Incentive Stock Options and Non-Qualified Stock Options to purchase 1,141,279 shares of common stock at exercise prices ranging from $6.75 to $36.11.

The following table summarizes information about stock options:

Transactions in FY20	Number of Options			Weighted- Average Exercise Price Per Share		Weighted- Average Remaining Contractual Life
Outstanding, August 31, 2019		1,163,259		$	12.63		7.13
Granted		34,500		$	35.57
Exercised		(29,445	)	$	8.11
Cancelled/Forfeited		(27,035	)	$	12.84
Outstanding, November 30, 2019		1,141,279		$	13.44		6.99
Exercisable, November 30, 2019		511,534		$	9.25		5.90

The weighted-average remaining contractual life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified SO, was 6.99 years at November 30, 2019. The total fair value of non-vested stock options as of November 30, 2019 was $10,559,000 and is amortizable over a weighted average period of 3.07 years.

The fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options, which do not have vesting restrictions and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including the expected stock price volatility. Because our stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its stock options.

The following table summarizes the fair value of the options, including both ISOs and NQSOs, granted during the current fiscal year 2020 and fiscal year 2019:

	YTD FY 2020		FY 2019
Estimated fair value of awards granted	$	401,580	$	1,928,820
Unvested Forfeiture Rate		0%		6.20%
Weighted average grant price	$	35.57	$	22.78
Weighted average market price	$	35.57	$	22.69
Weighted average volatility		32.15%		31.61%
Weighted average risk free rate		1.56%		2.59%
Weighted average dividend yield		0.68%		1.10%
Weighted average expected life		6.68 years		6.64 years

The exercise prices for the options outstanding at November 30, 2019 ranged from $6.75 to $36.11, and the information relating to these options is as follows:

Exercise Price				Awards Outstanding						Awards Exercisable
Low		High		Quantity		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Quantity		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price
$	6.75	$	8.00		212,753		4.77 years	$	6.84		212,753		4.77 years	$	6.85
$	8.01	$	16.00		604,376		6.88 years	$	9.97		274,381		6.70 years	$	9.94
$	16.01	$	24.00		242,650		8.55 years	$	20.68		24,400		6.84 years	$	22.56
$	24.01	$	36.11		81,500		9.72 years	$	34.80		0		0 years	$	0
					1,141,279		6.99 years	$	13.44		511,534		5.90 years	$	9.25

During the period ended November 30, 2019 the company issues 2,045 shares of stock to non-management directors of the Company valued at $72,411 as compensation for services rendered to the Company.